|
NNT and Drug Costs by CVD Risk Profile |
|||||||||
| Risk Category |
Placebo Risk |
Treatment Risk |
ARR |
NNT |
(95% CI) |
5-year NNT |
5-year Drug Cost Per Patient |
Total Cost |
Incremental Cost |
|
|
|||||||||
| 1 (low) |
0.1013 |
0.0814 |
0.0199 |
50 |
(18 – 59) |
45 |
$456 |
$20,529 |
$15,511 |
| 2 (medium) |
0.1476 |
0.0912 |
0.0564 |
18 |
(11 – 53) |
16 |
$456 |
$7,299 |
$2,281 |
| 3 (high) |
0.2044 |
0.1265 |
0.0779 |
13 |
(8 – 26) |
12 |
$456 |
$5,474 |
$456 |
| 4 (very high) |
0.2526 |
0.1699 |
0.0827 |
12 |
(7 – 38) |
11 |
$456 |
$5,018 |
$0 (base) |
Chen et al. Cost Effectiveness and Resource Allocation 2005 3:2 doi:10.1186/1478-7547-3-2 |
|||||||||